| 今开：0.0 | 昨收：0.378 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1418101.0 |
NeuBase Therapeutics(NBSE)05-14 04:35
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001104659-24-060568 Act: 34 Size: 211 KB 网页链接查看全文
NeuBase Therapeutics(NBSE)06-04 04:15
$NeuBase Therapeutics(NBSE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-067779 Act: 34 Size: 943 KB 网页链接查看全文
NeuBase Therapeutics(NBSE)05-14 18:05
$NeuBase Therapeutics(NBSE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-060759 Act: 34 Size: 18 KB 网页链接查看全文
NeuBase Therapeutics(NBSE)05-04 04:05
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 3.01 and 9.01 Accession Number: 0001104659-24-056957 Act: 34 Size: 206 KB 网页链接查看全文
NeuBase Therapeutics(NBSE)05-16 22:15
$NeuBase Therapeutics(NBSE)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-24-000350 Act: 34 Size: 3 KB 网页链接查看全文
NeuBase Therapeutics(NBSE)05-23 05:05
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001104659-24-064320 Act: 34 Size: 211 KB 网页链接查看全文
NeuBase Therapeutics(NBSE)05-06 19:35
$NeuBase Therapeutics(NBSE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-057213 Act: 34 Size: 19 KB 网页链接查看全文
NeuBase Therapeutics(NBSE)06-01 04:35
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 1.01, 3.02, 3.03, 5.03, 8.01, and 9.01 Accession Number: 0001104659-24-067212 Act: 34 Size: 291 KB 网页链接查看全文
药时代2022-10-20 14:32
前言
心理学告诉人们，永远不要在晚上做决定，因为那是不理性的。
但我不听劝（决定玩会手机），打开手机，又一则关于裁员的新闻弹出，让我陷入了思考。
我焦虑了，也失眠了。
新闻的题目是：“NeuBase放弃了亨廷顿舞蹈症，消减60%的劳动力作为战略支点”
还贴心附了...查看全文
$NeuBase疗法(NBSE)$ 3/A [Amend] Initial statement of beneficial ownership of securities Accession Number: 0001991925-23-000004 Size: 7 KB 网页链接
$NeuBase疗法(NBSE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001991925-23-000003 Size: 8 KB 网页链接
$NeuBase疗法(NBSE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001991925-23-000002 Size: 4 KB 网页链接
$NeuBase疗法(NBSE)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001991925-23-000001 Size: 7 KB 网页链接
$NeuBase疗法(NBSE)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001213900-23-072694 Act: 34 Size: 644 KB 网页链接
$NeuBase疗法(NBSE)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-23-014851 Act: 34 Size: 5 MB 网页链接
$NeuBase疗法(NBSE)$ ARS Annual Report to Security Holders Accession Number: 0001104659-23-090031 Act: 34 Size: 2 MB 网页链接
$NeuBase疗法(NBSE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-23-090027 Act: 34 Size: 340 KB 网页链接
$NeuBase疗法(NBSE)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-23-090024 Act: 34 Size: 2 MB 网页链接
$NeuBase疗法(NBSE)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-002343 Act: 33 Size: 1 KB 网页链接